Isostructural metabolites of two anti-Parkinson drugs

被引：2
|
作者：
Simon, K
Harmat, V
Torok, Z
Bocskei, Z
Hermecz, I
机构：
[1] Chinoin Chem & Pharmaceut Works Ltd, Dept Preclin Dev, H-1325 Budapest, Hungary
[2] Eotvos Lorand Univ, Dept Theoret Chem, H-1518 Budapest, Hungary
来源：
ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY | 1998年 / 54卷
关键词：
D O I：
10.1107/S0108270197019896
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The absolute configurations of desmethylselegiline hydrochloride [(R)-(-)-1-benzyl-N-(2-propynyl)ethylammonium chloride, C12H16N+.Cl-], (1), and p-fluorodesmethylselegiline hydrochloride [(R)-(-)-1-(4-fluorobenzyl)-N-(2-propynyl)ethylammonium chloride, C12H15FN+.Cl-], (2), have been determined. The two compounds are metabolites of the anti-Parkinson agent selegiline and its backup, p-fluoroselegiline. The two crystal structures are highly isostructural.
引用
收藏
页码：811 / 813
页数：3
相关论文
共 50 条
  • [1] ANTI-PARKINSON DRUGS IN PARANOID SCHIZOPHRENIA
    CAVENAR, JO
    BRAASCH, ER
    SULLIVAN, JL
    NORTH CAROLINA MEDICAL JOURNAL, 1979, 40 (05) : 287 - 288
  • [2] ANTI-PARKINSON DRUGS AND OREXIN NEURONS
    Katsuki, Hiroshi
    Michinaga, Shotaro
    VITAMINS AND HORMONES: SLEEP HORMONES, VOL 89, 2012, 89 : 279 - 290
  • [3] Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
    Bar Am, O
    Amit, T
    Youdim, MBH
    NEUROSCIENCE LETTERS, 2004, 355 (03) : 169 - 172
  • [4] The evolution of use of anti-Parkinson drugs in Spain
    Montané, E
    Vallano, A
    Castel, JM
    REVISTA DE NEUROLOGIA, 2002, 34 (07) : 612 - 617
  • [5] ABUSE OF THE ANTI-PARKINSON DRUGS - A REVIEW OF THE LITERATURE
    SMITH, JM
    JOURNAL OF CLINICAL PSYCHIATRY, 1980, 41 (10) : 351 - 354
  • [6] EFFECTS OF ANTI-PARKINSON DRUGS ON CORTICAL NEURONS
    CLARKE, G
    DAVIES, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (03) : 465 - 475
  • [7] METABOLISM OF ANTI-PARKINSON DRUGS - EXAMPLE OF COMPETITIVE HYDROXYLATION
    STOCK, B
    SPITELLER, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1979, 29-1 (04): : 610 - 615
  • [8] Fracture Risk Associated with Parkinsonism and Anti-Parkinson Drugs
    Peter Vestergaard
    Lars Rejnmark
    Leif Mosekilde
    Calcified Tissue International, 2007, 81 : 153 - 161
  • [9] POTENTIAL ANTI-PARKINSON DRUGS DESIGNED BY RECEPTOR MAPPING
    MARTIN, YC
    JARBOE, CH
    KRAUSE, RA
    LYNN, KR
    DUNNIGAN, D
    HOLLAND, JB
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (02) : 147 - 150
  • [10] Sleep attacks induced by anti-Parkinson disease drugs
    Miranda, M
    Díaz, V
    Venegas, P
    Villagra, R
    REVISTA MEDICA DE CHILE, 2001, 129 (05) : 585 - 586
12345